This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Biotech- and healthcare-related startups led the way as those companies dominate the list, taking a vast majority of spots. billion to develop data centers in Spain. In 2023, it partnered with Digital Realty to develop $7 billion in data centers targeting providers of online content, cloud services and artificial intelligence.
Earlier this week, life sciences venture firm Dimension Capital announced it had raised a new $500 million second fund just two years after its first to hunt for startups that are using artificial intelligence to develop new medicines. Venture funding to AI-related biotech and healthcare startups hit only $4.8
In the world of biotech, for example, it’s extremely capital intensive to develop multiple products that are all going through clinical trials simultaneously. A better approach would be to focus on a lead program — a single product that they can take through various stages of development, ultimately leading to FDA approval.
Product and service innovation: Software companies now sell AI-driven analytics as products, automakers offer AI features (like driver assist or predictive maintenance) as differentiators and healthcare firms use AI to develop new diagnostics and personalized medicine. Crucially, the time and cost to implement AI have fallen.
Biotech can often, and sometimes literally, fly over our heads. For IndieBio, a science and biotech accelerator run by VC firm SOSV, this unprecedented year offered high stakes and new challenges. Today and tomorrow, the biotech accelerator is hosting its twice-annual demo day.
Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. We will be hiring more top notch AI researchers, software engineers, medicinal chemists and biotech talent, as well as building our own research labs.”
We aim to cover a lot of food categories, but by replacing them with sustainable and nutritious ingredients.”. The firm is an investment fund focused on healthy food and sustainable agriculture, and often invests in companies that have impact and an analog to replace animal products. For example, white, spongy bread has milk proteins.
Play-to-earn games (P2E) are particularly susceptible to this problem, which is why “building a game that succeeds in the long term means developing monetization strategies that can weather market ebbs and flows,” says Corey Wilton, co-founder and CEO of Mirai Labs, the gaming studio behind Pegaxy. Development process. Budding Biotech.
Of course, biotech and fintech were in there too. tied) Serán Bioscience , $200M, biotech : The big biotech raise this week went to Serán Bioscience. The cash will be used to help complete AirPlant One, the company’s first sustainable aviation fuel plant. The company also announced it will rebrand to “Engine.”
According to a statement, the company will invest heavily in developing new manufacturing technologies across cell and gene therapies, viral vectors, vaccines and proteins. billion to spend on sustainability and health-focused biotech. “It Founded by ARCH Venture Partners investor Robert Nelsen, National Resilience Inc.,
Atarraya , creator of Shrimpbox, a sustainable “plug-and-play” shrimp farming technology, is swimming to the surface after being in stealth mode since 2019. We wanted to make the shrimp business more sustainable and more efficient without destroying the environment,” Russek said. “We million in Series A dollars, and a new U.S.
It’s hoped that if carbon dioxide could be converted at the point of emission, we could deal with the climate crisis a lot faster and create a sustainable carbon economy. Now Copenhagen-based biotech company SecondCircle thinks it also has a novel approach. There are a few companies trying to tackle this. It has raised $310.4
A prominent figure in life sciences innovation, Imran has founded over 20 medical device companies and helped develop the world’s first implantable cardiac defibrillator. In January 2020, their acromegaly treatment, Octreotide, demonstrated both safety and sustained bioavailability in primary clinical trials.
Boost Biomes , the Y Combinator-backed developer of microbiome-based bio-fungicides and bio-pesticides for agricultural applications, has added $2 million in funding and picked up a new strategic investor in Japan’s Universal Materials Incubator. We also expect Boost’s huge potential on other areas where microbiomes are utilized.”
MEDU , a Mexico-based startup, wants to reduce that waste and replace single-wear medical garments through the creation of a line of sustainable, virus-resistant reusable pieces, including surgical gowns, head coverings and full-body suits. and continues development of its full-body suit. by the end of the year.
The Importance of Executive Search and Leadership Development to the Growth of the Life Sciences Industry Ensuring that organizations have access to top talent for key leadership positions and that talent is sufficiently supported and developed is critical to the growth of the life sciences industry.
Targeting cosmetics brands, the London-based biotech startup has scooped up a $6.2 Our vision is to break the reliance on the petroleum industry by building a new standard of packaging that is performant, cost competitive and truly sustainable,” said CEO Insiya Jafferjee, who co-founded Shellworks after spending nearly three years at Apple.
CEO Brian Spears has a chemical engineering background and co-founded the company, which makes meat from animal cells, in 2018 after spending 12 years developing research laboratory and industry automation. “We
Hong Kong-based drug discovery and development company Insilico has secured fresh capital at a time that its CEO described as a “biotech winter.” “Prosperity7 inspired us to look into sustainable chemistry,” said Zhavoronkov.
It occurred to him that automation and robotics could make the drug development process more predictable, and so he founded Katakem , one of the startups in the TechCrunch Disrupt Battlefield 200. ” To Oliverio’s point, drug development today is a lengthy and expensive endeavor. . Food and Drug Administration. million ($1.27
This led her to pair up with David Hachuel to develop a way to make eating a painless ritual for 40 million other Americans also suffering from IBS. Ultimately, fiber is good for you, and removing it from the diet is not sustainable,” Wallach added. 2021 should be a banner year for biotech startups that make smart choices early.
To meet these challenges, we leverage our healthcare sector knowledge and a rigorously developed methodology that goes beyond reviewing a candidates CV. They must be capable of aligning financial sustainability with compassionate, patient-centric care. In short, effective executive search in healthcare transcends filling vacancies.
A solid online presence is crucial for conveying the complexities of biotech innovations while attracting stakeholders. This article explores strategies for enhancing the impact and visibility of your biotech website, ensuring it captures and retains your audience’s attention. A clear focus on biotech website design is essential.
There are even startups looking into that, like Shiru, which recently raised $17 million to develop more healthier bonding agents for meat. Boyd Myers noted those claims were inspiration for how AKUA approached developing the ingredient list for its kelp burger, which has 15 ingredients , all of which are food or food-derived.
However, it wasn’t just AI that got funding in September, as biotech makes up about half the list. Candid Therapeutics , $370M, biotech: The biggest biotech raise of the month went to Candid Therapeutics. Candid is developing T-cell engager antibodies to treat inflammatory diseases.
Louis, Missouri-based venture capital firm soon after completing high school, 23-year-old Williams has backed dozens of companies — with a special interest in agtech and biotech and including a couple of very large tech companies that he’s not at liberty to mention. An early win we had was with Agrible and its sale to Nutrien.
The industrial biotech startup is working on bringing a novel protein to market — one it says will offer a nutritious, sustainable alternative to animal-derived proteins. “We leave the final formulation and product development for our customers so that we can empower them to renew categories,” he suggests.
At the same time, in most developed countries older adults are accounting for an unprecedented share of the population. In tandem, a large cohort of startups have scaled up over the past few years with offerings aimed at slowing, sustaining or even shaving years off biological age. We are all getting older. In the U.S.,
The process involves synthetic biology, deep learning and genomics tools that produce fats that are more sustainable than the current oils, like coconut, that are used in plant proteins, but also mimic animal-based analogs in terms of flavor and texture, CEO Yulin Lu told TechCrunch.
Our survey respondents think the ecosystem is strong in sustainable energy, medtech, food tech, life sciences, marketplaces, deep tech, gaming and media. The investment scene is described variously as focusing on software, clean tech, life sciences, biotech, organoids, 3D bioprinting, AI and VR/AR. Utrecht is a bit lagging.”
After a quiet holiday week, investors were back in action dishing out big rounds to startups in robotics, biotech, healthcare and more. Element Biosciences , $277M, biotech: It’s hard to get through a week without a big biotech raise, and this one’s no different. based companies? Check out The Crunchbase Megadeals Board.
Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. The San Francisco-based company has developed a telenutrition and food benefits management platform.
Now with 35 employees and new financing, the company is trying to shift from research and development into a food production company. Strategic investors like DSM, one of the largest food biotech companies in Europe should help. That’s including the fat and connective tissue that makes meat… well… meat.
Nature’s Fynd, which raised $350 million in a Series C round in 2021, created Fy, a vegan protein that can be used as a solid, liquid or powder to make sustainable foods, like meat and cheese. Meet retail’s new sustainability strategy: Personalization.
Discovery and research of new molecular compounds is an expensive business, with development costs exceeding $10 billion per substance in some cases. Nanome streamlines this process by bringing researchers to the same virtual reality space to work on molecule development together.
based company, founded in 2019 by Jevan Nagarajah, is still in the R&D phase of developing animal-free cheeses using precision fermentation. While other food tech companies are tackling softer cheeses like mozzarella or whey proteins, Better Daily is targeting hard cheeses, a process that is more complex, in a more sustainable way.
Founded in 2012, the accelerator is focused on developing early-stage companies tied to the University of California system. Building on technologies developed in the stem cell research labs of UCSF, EndoCrine is looking to commercialize a better way to discover and develop drugs. Image Credits: EndoCrine Bio, Inc. The Hurd Co.
The company — a utility-scale solar and energy storage project development, ownership and operations platform — will use the new capital to grow its “high value project development pipeline.” tied) Accent Therapeutics , $75M, biotech: Another week, another big biotech round.
“The model that we’ve been developing, that’s been working really well and we feel like this is the opportunity to really scale it in a very major way. We saw it multiple times, with lab testing, with antigen testing and now with vaccines,” Color CEO and co-founder Othman Laraki told me in an interview.
Big deals The largest startup funding round in April was a $1 billion deal to stealth startup Xaira Therapeutics for drug development using AI. Top sectors Biotech and healthcare was the leading sector by funding amount in April.
Money still coming Investors in the space — which is broad and includes several areas of sectors such as biotech, manufacturing and climate tech — agree that while there has undoubtedly been a slow down in investing, the wide breadth of deep tech and the importance of the problems it is looking to solve has kept money flowing.
It’s been a big two years for biotech investors. Soliome – Soliome wants to reinvent the way we develop sunscreen. Specifically, this team has managed to grow microbes only found in the La Puna desert (an area described as “Mars on Earth” ), where they’ve managed to sustain plant life. The Cohort.
Backers in the round include EVIG Group, Stray Dog Capital, E2JDJ, Tet Ventures, Good Seed Ventures, Sustainable Food Ventures and Shio Capital. Unlike dairy, where there is already sustainability, she believes the egg is still largely untapped. Today, the company announced it raised $2.8
While countless companies are developing alternative and more sustainable ways for humans to get their protein fixes such as through lab-grown meat , others are tackling the underlying problem from a different angle by exploring new ways of fostering the traditional meat and fish populace through insect protein.
We organize all of the trending information in your field so you don't have to. Join 49,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content